Adagene Inc. declares multi-target platform evaluation with Celgene
Adagene Inc., an innovative clinical-stage biotechnology firm, has made it to the front page with…
TLC and 3SBio partner to commercialize two NanoX products in China
A clinical-stage specialty pharmaceutical company Taiwan Liposome Company Ltd. and 3SBio Inc, China’s leading biopharmaceutical…
Biocartis confirms CE-IVD marking of Idylla™ MSI Test for CRC patients
Innovative molecular diagnostics firm Biocartis Group NV has recently announced the CE-IVD marking of its…
U.S. FDA grants Fast Track designation for Iovance’s LN-145 therapy
With the Fast Track designation, Iovance is likely to increase the frequency of its communication…
Bausch Health announces FDA Approval for its LOTEMAX SM 0.38%
In a recent turn of events, Bausch + Lomb, an eye health behemoth and a…
AstraZeneca’s Brilinta clears THEMIS trial with 19,000-plus patients
In a recent turn of events, biopharmaceutical giant AstraZeneca’s Brilinta has reportedly cleared its phase…
Roche to accelerate position in gene therapy with Spark acquisition
Roche Holding AG, the Swiss healthcare giant, has reportedly announced its acquisition of the U.S.-based…
AusCann signs deal with MediPharm Labs to purchase cannabis resin
The latest move underlines MediPharm’s first international export deal. AusCann Group Holdings Ltd. (AC8), an…
Reata announces positive results from bardoxolone phase 2 study
The study specifies the possibility of preventing or delaying kidney failure and the need for…